Alivus Life Sciences Limited · NSE: ALIVUS · BSE: 543322

Alivus Life Sciences

Quarterly results as filed with BSE. Latest: Q1 FY27 (Apr–Jun 2026), filed 30 Jul 2026.

Q1 FY27 · Standalone

Revenue
640.41₹ Cr
+6.4% vs year ago
Net profit
160.08₹ Cr
+31.7% vs year ago
EPS, basic
13.04₹
+31.6% vs year ago
Net margin
25.0%
+4.8 pts vs year ago
Revenue₹ crore · standalone · last 12 quarters
Q2 FY24: ₹595.36 CrQ3 FY24: ₹572.80 CrQ4 FY24: ₹536.60 CrQ1 FY25: ₹588.62 CrQ2 FY25: ₹506.88 CrQ3 FY25: ₹641.84 CrQ4 FY25: ₹649.54 CrQ1 FY26: ₹601.85 CrQ2 FY26: ₹587.98 CrQ3 FY26: ₹672.89 CrQ4 FY26: ₹689.12 CrQ1 FY27: ₹640.41 CrQ3 ’24Q1 ’25Q3 ’25Q1 ’26Q3 ’26Q1 ’27
Net profit₹ crore · standalone · last 12 quarters
Q2 FY24: ₹118.74 CrQ3 FY24: ₹118.77 CrQ4 FY24: ₹97.94 CrQ1 FY25: ₹111.48 CrQ2 FY25: ₹95.32 CrQ3 FY25: ₹136.96 CrQ4 FY25: ₹141.87 CrQ1 FY26: ₹121.53 CrQ2 FY26: ₹130.03 CrQ3 FY26: ₹150.26 CrQ4 FY26: ₹162.66 CrQ1 FY27: ₹160.08 CrQ3 ’24Q1 ’25Q3 ’25Q1 ’26Q3 ’26Q1 ’27

Quarter by quarter

Standalone · ₹ crore
QuarterRevenueYoYNet profitYoYEPS (₹)Filed
Q1 FY27Apr–Jun 2026640.41+6.4%160.08+31.7%13.0430 Jul 2026
Q4 FY26Jan–Mar 2026689.12+6.1%162.66+14.7%13.2314 May 2026
Q3 FY26Oct–Dec 2025672.89+4.8%150.26+9.7%12.2522 Jan 2026
Q2 FY26Jul–Sep 2025587.98+16.0%130.03+36.4%10.6006 Nov 2025
Q1 FY26Apr–Jun 2025601.85+2.2%121.53+9.0%9.9101 Aug 2025
Q4 FY25Jan–Mar 2025649.54+21.0%141.87+44.9%11.5715 May 2025
Q3 FY25Oct–Dec 2024641.84+12.1%136.96+15.3%11.1823 Jan 2025
Q2 FY25Jul–Sep 2024506.88−14.9%95.32−19.7%7.7825 Oct 2024
Q1 FY25Apr–Jun 2024588.62+1.8%111.48−17.7%9.1029 Jul 2024
Q4 FY24Jan–Mar 2024536.60−13.6%97.94−33.1%7.9926 Apr 2024
Q3 FY24Oct–Dec 2023572.80+5.9%118.77+13.1%9.6924 Jan 2024
Q2 FY24Jul–Sep 2023595.36+16.9%118.74+11.1%9.6931 Oct 2023
Q1 FY24Apr–Jun 2023578.45+18.1%135.45+24.6%11.0521 Jul 2023
Q4 FY23Jan–Mar 2023621.32+20.9%146.36+48.0%11.9429 Apr 2023
Q3 FY23Oct–Dec 2022540.73+3.5%104.99+1.2%8.5727 Jan 2023
Q2 FY23Jul–Sep 2022509.30−9.3%106.88−7.2%8.7224 Oct 2022
Q1 FY23Apr–Jun 2022489.87−6.7%108.73+7.7%8.8708 Aug 2022
Q4 FY22Jan–Mar 2022514.06—98.90—8.0721 Apr 2022
Q3 FY22Oct–Dec 2021522.50—103.71—8.6508 Feb 2022
Q2 FY22Jul–Sep 2021561.76—115.20—9.8311 Nov 2021
Q1 FY22Apr–Jun 2021524.90—100.91—9.3616 Aug 2021

21 filings on record for this company.